Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study

HIV Medicine
B T RøgeJ Gerstoft

Abstract

To investigate the interplay between resistance and adherence in the virological failure of three fundamentally different highly active antiretroviral therapy (HAART) regimens. We retrospectively identified 56 verified primary virological failures (viral load >400 HIV-1 RNA copies/mL) among 293 patients randomized to two nucleoside reverse transcriptase inhibitors (NRTIs)+ritonavir+saquinavir (RS-arm) (n=115), two NRTIs+nevirapine+nelfinavir (NN-arm) (n=118), or abacavir+stavudine+didanosine (ASD-arm) (n=60) followed up for a median of 90 weeks. Data on adherence were collected from patient files, and genotyping was performed on plasma samples collected at time of failure. Treatment interruption or poor adherence was mainly caused by side effects and accounted for 74% of failures, and was associated with absence of resistance mutations. In the 30 failing patients not switched from randomized treatment, we found resistance in two of 12 patients in the RS-arm (M184 V only), four of six patients in the NN-arm [all four had non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations], and seven of 12 patients in the ASD-arm (NRTI mutations only). Two adherent patients on randomized treatment failed in the RS-arm, none in the N...Continue Reading

References

Jan 14, 2000·JAMA : the Journal of the American Medical Association·D V HavlirD D Richman
Mar 27, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·S G Deeks
May 16, 2001·Annals of Internal Medicine·B J Turner, F M Hecht
Jul 13, 2001·Antiviral Research·R G JainJ M Lenhard
Dec 26, 2001·The Journal of General Virology·Maria Dolores Iglesias-UsselCecilio López-Galíndez
Jun 28, 2002·The New England Journal of Medicine·Sharon WalmsleyUNKNOWN M98-863 Study Team
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Patrick G YeniPaul A Volberding
Jul 20, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·John Christopher WalshBrian George Gazzard
Aug 2, 2002·The Journal of the Association of Nurses in AIDS Care : JANAC·Gwen van ServellenMary J Tichacek
Sep 11, 2002·Antiviral Research·Peter BorowskiHerbert Schmitz
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Odile LaunayUNKNOWN Agence Nationale de Recherches sur le SIDA (ANRS) 081 Study Group
Oct 31, 2002·The Journal of Infectious Diseases·Bernard MasquelierUNKNOWN APROCO Study Group

❮ Previous
Next ❯

Citations

Mar 2, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Maria L EkstrandGirija Singh
May 24, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xiuhong LiLisa P Jacobson
Oct 7, 2006·The Journal of Antimicrobial Chemotherapy·R S BraithwaiteA C Justice
Apr 27, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Babafemi O TaiwoRobert L Murphy
Oct 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Suely H TuboiMauro Schechter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.